ArTS Archivio della ricerca di Trieste

STOCCO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.966
EU - Europa 8.975
AS - Asia 7.240
SA - Sud America 1.015
AF - Africa 284
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 6
Totale 30.521
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.721
PL - Polonia 2.590
SG - Singapore 2.520
IT - Italia 2.050
CN - Cina 1.517
VN - Vietnam 841
BR - Brasile 765
SE - Svezia 743
HK - Hong Kong 663
DE - Germania 655
BD - Bangladesh 461
FI - Finlandia 451
FR - Francia 433
UA - Ucraina 429
GB - Regno Unito 380
KR - Corea 302
RU - Federazione Russa 292
NL - Olanda 238
IN - India 206
TR - Turchia 197
IE - Irlanda 170
BG - Bulgaria 137
JP - Giappone 113
CA - Canada 99
AR - Argentina 87
MA - Marocco 82
MX - Messico 81
BE - Belgio 62
AT - Austria 61
ES - Italia 57
IQ - Iraq 54
ZA - Sudafrica 48
PK - Pakistan 47
SA - Arabia Saudita 45
SN - Senegal 45
EC - Ecuador 37
ID - Indonesia 37
PH - Filippine 31
EG - Egitto 30
PT - Portogallo 29
AU - Australia 28
TH - Thailandia 26
VE - Venezuela 26
CL - Cile 25
CO - Colombia 24
CH - Svizzera 22
CZ - Repubblica Ceca 21
IR - Iran 21
LT - Lituania 21
PE - Perù 21
UZ - Uzbekistan 21
TN - Tunisia 20
JO - Giordania 19
GR - Grecia 16
PY - Paraguay 15
RO - Romania 15
CR - Costa Rica 14
TW - Taiwan 14
AZ - Azerbaigian 13
MY - Malesia 13
SI - Slovenia 13
DK - Danimarca 12
DZ - Algeria 12
RS - Serbia 12
AE - Emirati Arabi Uniti 10
IL - Israele 10
NO - Norvegia 10
KE - Kenya 9
KW - Kuwait 9
AL - Albania 8
JM - Giamaica 8
MD - Moldavia 8
UY - Uruguay 8
GT - Guatemala 7
HR - Croazia 7
NP - Nepal 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 6
ET - Etiopia 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
BA - Bosnia-Erzegovina 5
DO - Repubblica Dominicana 5
GE - Georgia 5
MN - Mongolia 5
PA - Panama 5
CI - Costa d'Avorio 4
EE - Estonia 4
HN - Honduras 4
HU - Ungheria 4
KG - Kirghizistan 4
LB - Libano 4
LU - Lussemburgo 4
LV - Lettonia 4
NG - Nigeria 4
NI - Nicaragua 4
PR - Porto Rico 4
SV - El Salvador 4
BH - Bahrain 3
CG - Congo 3
Totale 30.461
Salva come PNG Salva come JPEG
Città #
Warsaw 2.411
Ashburn 1.476
Singapore 1.458
Woodbridge 1.051
Fairfield 1.014
Ann Arbor 924
Chandler 800
San Jose 749
Trieste 657
Houston 641
Hong Kong 629
Wilmington 500
Seattle 445
Jacksonville 384
Cambridge 343
Beijing 340
Munich 294
Seoul 279
Ho Chi Minh City 276
Hefei 258
Helsinki 242
Council Bluffs 240
Princeton 232
Boardman 225
Los Angeles 209
Hanoi 199
Chicago 183
Dublin 152
Lauterbourg 150
Santa Clara 150
Milan 148
Dallas 147
Moscow 138
Izmir 136
New York 135
Sofia 135
Columbus 133
Zgierz 133
London 121
Frankfurt am Main 96
The Dalles 95
Rome 94
Dearborn 91
Buffalo 85
São Paulo 83
Tokyo 66
Casablanca 65
Düsseldorf 55
Orem 54
Brussels 51
San Diego 50
Shanghai 47
Dakar 45
Atlanta 43
Lappeenranta 43
Dong Ket 42
Phoenix 42
Redondo Beach 41
Memphis 37
Nuremberg 37
Vienna 37
Redwood City 36
Turku 36
Falls Church 33
Montreal 33
Chennai 32
Denver 32
Manchester 32
Mumbai 32
Amsterdam 30
Guangzhou 30
Toronto 29
Da Nang 28
Johannesburg 28
Nanjing 27
Stockholm 27
Haiphong 26
Des Moines 25
Bologna 24
Brooklyn 24
Curitiba 24
Washington 24
Boston 23
Jinan 23
Bremen 22
Rio de Janeiro 21
Wroclaw 21
Belo Horizonte 20
Genoa 20
Istanbul 20
Tianjin 20
Baghdad 19
Hangzhou 19
Pune 19
Tashkent 19
Brno 18
Redmond 18
Shenyang 18
Sydney 18
Kunming 17
Totale 20.403
Salva come PNG Salva come JPEG
Nome #
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis 536
5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis 527
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 512
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 470
Role of Oxidative Stress Mediated by Glutathione-S-transferase in Thiopurines' Toxic Effects 456
Pharmacogenetics of thiopurines 451
BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress 447
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms 430
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children 428
Genetic determinants for methotrexate response in juvenile idiopathic arthritis 415
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients 415
Type i interferon-mediated autoinflammation due to DNase II deficiency 404
Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis? 403
Pharmacogenetics of treatments for inflammatory bowel disease 381
In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome 342
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 329
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease 313
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia 309
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 301
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response 292
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 291
Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. 287
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 285
Contribution of Glutathione-S-Transferases to the Pharmacogenetics of Azathioprine 278
Ergothioneine, a dietary amino acid with a high relevance for the interpretation of label-free surface enhanced Raman scattering (SERS) spectra of many biological samples 270
Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy 269
NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells 268
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients 266
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives 266
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events 265
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients 264
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 262
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn's disease 260
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease. 259
ABCB1 and ABCC1 variants associated with virological failure of first-line protease inhibitors antiretroviral regimens in Northeast Brazil patients. 258
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 256
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 255
Opioid Resistance Associated with CYP3A4 Hyperactivity and COMT Polymorphism in an Oncological Patient 253
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay 251
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease 251
Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient 250
Novel motif of variable number of tandem repeats in TPMT promoter region and evolutionary association of variable number of tandem repeats with TPMT∗3 alleles 249
Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse. 242
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort 240
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs 238
Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies 236
Glutathione-S-Transferase-P1 I105V polymorphism and response to antenatal betamethasone in the prevention of respiratory distress syndrome 233
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease 233
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 230
Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? 229
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor 226
Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease 224
Pharmacogenomic approaches for tailored anti-leukemic therapy in children. 224
SERS of cells: What can we learn from cell lysates? 223
ABCB1 gene polymorphisms and expression of P-glycoprotein and long term prognosis in colorectal cancer 222
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias 222
Effect of periodontal therapy on the course of cyclosporin-induced gingival overgrowth: role of ABCB1 and PAI-1 gene polymorphisms. 216
A Validated HPLC-Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside 215
Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response. 210
Genetic Predictors of Glucocorticoid Response in Pediatric Patients With Inflammatory Bowel Diseases 207
Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease. 203
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. 203
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease 201
Personalized therapies in pediatric inflammatory and autoimmune diseases. 201
Letter: TPMT activity and age in IBD patients. 200
Usefulness of the measurement of azathioprine metabolites in the assessment of non-adherence 195
Cancer Pharmacogenomics 192
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. 192
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention 187
Distinct effects of dinuclear ruthenium(III) complexes on cell proliferation and on cell cycle regulation in human and murine tumor cell lines. 186
Inflammatory Bowel Disease 184
Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel disease 183
Emerging molecular mechanisms underlying cancer metastasis: the rising role of the long non-coding RNA GAS5 182
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 182
Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease. 181
Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease 179
MICRORNAS ARE INVOLVED IN GLUCOCORTICOID RESISTANCE REVERSION BY RAPAMYCIN THROUGH SUPPRESSION OF THE JNK SIGNALING PATHWAY 178
DMET™ Plus array delivers results in good concordance with those of several lower-throughput genotyping methods in patient samples. 177
Pharmacogenetics, cost of genotyping, and guidelines for individualizing therapy with mercaptopurine in pediatric acute lymphoblastic leukemia. 174
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity. 173
Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients 171
Expression profiles of the lncRNA antisense GAS5-AS1 in colon biopsies from pediatric inflammatory bowel disease patients and its role in regulating sense transcript GAS5 169
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway 168
Preanalytical Stability of 13 Antibiotics in Biological Samples: A Crucial Factor for Therapeutic Drug Monitoring 168
Pharmacological evaluation of drug therapies in Aicardi-Goutières syndrome: insights from patient-derived neural stem cells 167
Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease 167
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease 167
Quantification of 7 cannabinoids in cannabis oil using GC-MS: Method development, validation and application to therapeutic preparations in Friuli Venezia Giulia region, Italy 166
TPMT genotype and the use of thiopurines in pediatric inflammatory bowel disease. 165
Systematic identification of host genomic variation related to treatment outcome of childhood acute lymphoblastic leukemia 165
PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells 164
In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile 164
Glucocorticoid receptor polymorphisms in inflammatory bowel disease. 162
Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia 162
Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress 162
A new proof of evidence of cysteamine quantification for therapeutic drug monitoring in patients with cystinosis 159
Induced pluripotent stem cells as a model for therapy personalizationof pediatric patients: Disease modeling and drug adverse effects prevention 159
Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia 158
Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status 156
Processes for incorporation of pharmacogenetic tests and interpretations in medical records for clinical practice. 156
Totale 25.072
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.214
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021188 0 0 0 0 0 0 0 0 0 0 0 188
2021/20221.581 100 110 90 140 40 141 122 55 180 161 95 347
2022/20232.390 237 370 161 347 223 373 22 204 264 49 89 51
2023/20241.698 76 99 64 101 176 144 298 331 30 53 205 121
2024/20254.788 96 257 353 417 390 539 330 341 645 579 379 462
2025/202610.549 995 520 689 872 891 858 1.427 370 1.190 1.370 869 498
Totale 31.208